Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma.
Wang J, Jordan AR, Zhu H, Hasanali SL, Thomas E, Lokeshwar SD, Morera DS, Alexander S, McDaniels J, Sharma A, Aguilar K, Sarcan S, Zhu T, Soloway MS, Terris MK, Thangaraju M, Lopez LE, Lokeshwar VB.
Wang J, et al. Among authors: lokeshwar sd, lokeshwar vb.
Cancer Cell Int. 2022 Dec 29;22(1):421. doi: 10.1186/s12935-022-02818-1.
Cancer Cell Int. 2022.
PMID: 36581895
Free PMC article.